News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
321 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (18147)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (4)
2 (136)
3 (68)
4 (1)
5 (9)
6 (312)
7 (276)
8 (247)
9 (293)
10 (149)
11 (2)
12 (29)
13 (321)
14 (194)
15 (184)
16 (169)
17 (84)
18 (2)
19 (7)
20 (77)
21 (244)
22 (181)
23 (159)
24 (88)
25 (4)
26 (6)
27 (176)
28 (222)
29 (171)
30 (232)
31 (105)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular degeneration (AMD) and Diabetic Macular Oedema (DMO)
The program, facilitated by Johnson & Johnson Innovation, has the potential to improve the treatment of patients with retinal vascular diseases and transform the lives of those suffering from vision loss.
January 13, 2020
·
4 min read
Biotech Beach
HealthLytix Joins Nuance AI Marketplace for Diagnostic Imaging
Summary: HealthLytix’s CT CoPilot software for head CT exams to be available to users of Nuance PowerScribe™, the radiology reporting system trusted by approximately 80 percent of U.S. radiologists across more than 7,000 connected healthcare facilities.
January 13, 2020
·
3 min read
ERS Genomics Licenses CRISPR Gene Editing Technology to Daiichi Sankyo to Support Internal Research and Development
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, announced the signing of a license agreement with Daiichi Sankyo, a global pharmaceutical company with corporate origins in Japan.
January 13, 2020
·
1 min read
Biotech Bay
200G HDR InfiniBand to Accelerate the New European Centre for Medium-Range Weather Forecasts (ECMWF) Supercomputer
The HDR InfiniBand Connected Supercomputer Will Increase the Center’s Weather and Climate Research Compute Power by Five Times, Enabling Enhanced and Far More Accurate Forecast and Predictions
January 13, 2020
·
4 min read
Genetown
bluebird bio Announces Launch in Germany of ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent β-Thalassemia Who Do Not Have β0/β0 Genotype
First agreements with statutory health insurances utilize bluebird’s innovative value-based payment model and provide coverage for ZYNTEGLO for up to 50% of patients in Germany
January 13, 2020
·
8 min read
Deals
Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences
Collaboration Brings Together Gilead’s Commitment to Advancing Cell Therapy with Kyverna’s Focus on Advanced T Cell Engineering Targeting Autoimmune Diseases
January 13, 2020
·
6 min read
Business
Itamar™ Medical Announces Preliminary Revenue for Fourth Quarter and Full Year 2019 and Revenue Guidance for Full Year 2020
Itamar Medical Ltd. reported preliminary unaudited revenue results for the fourth quarter and full year ended December 31, 2019 and announced revenue guidance for the full year 2020.
January 13, 2020
·
5 min read
Business
Emergent BioSolutions Announces Preliminary 2019 Financial Results and Provides 2020 Financial Forecast
Emergent BioSolutions Inc. announced selected preliminary unaudited 2019 financial results and its financial forecast for 2020.
January 13, 2020
·
13 min read
Biotech Beach
Novus Therapeutics Provides Update on OP0201
Phase 2a study C-006 enrollment to be completed in 1Q 2020; data expected in 2Q 2020
January 13, 2020
·
5 min read
Drug Development
Zynerba Pharmaceuticals Announces Achievement of Enrollment Target in Phase 2 Trial of Zygel™ in Autism Spectrum Disorder
Zynerba Pharmaceuticals, Inc., announced the achievement of its enrollment target for the 14-week Phase 2 BRIGHT trial of Zygel™ for the treatment of pediatric and adolescent patients with autism spectrum disorder.
January 13, 2020
·
7 min read
Previous
30 of 33
Next